124 related articles for article (PubMed ID: 3258563)
1. T cell recognition of endogenous IgG2a expressed in B lymphoma cells.
Bikoff EK; Yu H; Eckhardt LA
Eur J Immunol; 1988 Mar; 18(3):341-8. PubMed ID: 3258563
[TBL] [Abstract][Full Text] [Related]
2. T cell clones specific for IgG2a of the a allotype: direct evidence for presentation of endogenous antigen.
Bikoff E; Birshtein BK
J Immunol; 1986 Jul; 137(1):28-34. PubMed ID: 2423605
[TBL] [Abstract][Full Text] [Related]
3. Presentation of IgG2a antigens to class II-restricted T cells by stably transfected B lymphoma cells.
Bikoff EK; Eckhardt LA
Eur J Immunol; 1989 Oct; 19(10):1903-9. PubMed ID: 2479567
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of mouse T lymphocyte-induced suppression of the IgG2ab allotype and T lymphocyte tolerance to IgG2ab.
Majlessi L; Bordenave G
Arch Immunol Ther Exp (Warsz); 2001; 49(6):407-15. PubMed ID: 11814234
[TBL] [Abstract][Full Text] [Related]
5. The T cell response to allelic determinants on Igh-1-encoded IgG2a antibodies: dual recognition examined by using antigenic antibodies with binding affinity for Ia molecules.
Hedrick SM; Schwartz RH
J Immunol; 1983 Apr; 130(4):1958-66. PubMed ID: 6187829
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin-specific T-B cell interaction. II. T cell clones recognize the processed form of B cells' own surface immunoglobulin in the context of the major histocompatibility complex class II molecule.
Yurin VL; Rudensky AY; Mazel SM; Blechman JM
Eur J Immunol; 1989 Sep; 19(9):1685-91. PubMed ID: 2507327
[TBL] [Abstract][Full Text] [Related]
7. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.
Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C
Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420
[TBL] [Abstract][Full Text] [Related]
8. DNA-mediated transfer of major histocompatibility class II I-Ab and I-Abm12 genes into B lymphoma cells: molecular and functional analysis of introduced antigens.
Ben-Nun A; Choi E; McIntyre KR; Leeman SA; McKean DJ; Seidman JG; Glimcher LH
J Immunol; 1985 Aug; 135(2):1456-64. PubMed ID: 3925010
[TBL] [Abstract][Full Text] [Related]
9. Mixed haplotype A beta Z/A alpha d class II molecule in (NZB x NZW)F1 mice detected by T cell clones.
Gotoh Y; Takashima H; Noguchi K; Nishimura H; Tokushima M; Shirai T; Kimoto M
J Immunol; 1993 Jun; 150(11):4777-87. PubMed ID: 8496588
[TBL] [Abstract][Full Text] [Related]
10. Efficiency of antigen presentation to T cell clones by (B cell X B cell lymphoma) hybridomas correlates quantitatively with cell surface ia antigen expression.
Bekkhoucha F; Naquet P; Pierres A; Marchetto S; Pierres M
Eur J Immunol; 1984 Sep; 14(9):807-14. PubMed ID: 6332737
[TBL] [Abstract][Full Text] [Related]
11. Downmodulation of antigen presentation by H2-O in B cell lines and primary B lymphocytes.
Brocke P; Armandola E; Garbi N; Hämmerling GJ
Eur J Immunol; 2003 Feb; 33(2):411-21. PubMed ID: 12645938
[TBL] [Abstract][Full Text] [Related]
12. T cell allotypic determinants encoded by genes linked to the immunoglobulin heavy chain locus. I. Establishment of monoclonal antibodies against allotypic determinants.
Aihara Y; Tadokoro I; Katoh K; Minami M; Okuda K
J Immunol; 1983 Jun; 130(6):2920-5. PubMed ID: 6406598
[TBL] [Abstract][Full Text] [Related]
13. Class II MHC molecules are spontaneously internalized in acidic endosomes by activated B cells.
Weber DA; Buck LB; Delohery TM; Agostino N; Pernis B
J Mol Cell Immunol; 1990; 4(5):255-66; discussion 266-8. PubMed ID: 2169757
[TBL] [Abstract][Full Text] [Related]
14. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
[TBL] [Abstract][Full Text] [Related]
15. Requirement for recognition of class II molecules and processed tumor antigen for optimal generation of syngeneic tumor-specific class I-restricted CTL.
Kern DE; Klarnet JP; Jensen MC; Greenberg PD
J Immunol; 1986 Jun; 136(11):4303-10. PubMed ID: 2422280
[TBL] [Abstract][Full Text] [Related]
16. Engagement of the B lymphocyte antigen receptor induces presentation of intrinsic immunoglobulin peptides on major histocompatibility complex class II molecules.
Bartnes K; Hannestad K
Eur J Immunol; 1997 May; 27(5):1124-30. PubMed ID: 9174601
[TBL] [Abstract][Full Text] [Related]
17. IA mutant functional antigen-presenting cell lines.
Glimcher LH; Hamano T; Asofsky R; Sachs DH; Pierres M; Samelson LE; Sharrow SO; Paul WE
J Immunol; 1983 May; 130(5):2287-94. PubMed ID: 6300242
[TBL] [Abstract][Full Text] [Related]
18. Activation of autoreactive T-cell clones from NZB.H-2bm12 mice.
Naiki M; Yoshida SH; Ansari AA; Bill J; Gershwin ME
J Autoimmun; 1994 Jun; 7(3):275-90. PubMed ID: 7916904
[TBL] [Abstract][Full Text] [Related]
19. H-2-linked Ir gene control of VH determinant(s)-specific helper T cells.
Kawahara DJ; Marrack P; Kappler JW
J Mol Cell Immunol; 1986; 2(5):255-64. PubMed ID: 2978232
[TBL] [Abstract][Full Text] [Related]
20. T cell activation by processed antigen is equally blocked by I-E and I-A-restricted immunodominant peptides.
Lakey EK; Casten LA; Anderson MS; Smolenski LA; Smith JA; Margoliash E; Pierce SK
Eur J Immunol; 1987 Nov; 17(11):1605-9. PubMed ID: 3500065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
